Japan’s Pharmaceuticals and Medical Devices Agency (PMDA) Renews Licenses of Certara’s Biosimulation Software for Evaluating Regulatory Submissions
The PMDA enters 8th consecutive year of using Certara’s biosimulation softwarePRINCETON, N.J., June 23, 2021 (GLOBE NEWSWIRE) — Certara, a…